Insider Trades79 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 4,340 | $21.55 | $2.5B | -40.82% | +26.46% | $93.5K | +0.00% | 10b5-1 | Stalk |
| Jul 21, 2026 | Sell | MLYS | Eric Warren | Chief Commercial Officer | 14,876 | $20.06 | $2.5B | -40.82% | +26.46% | $298.4K | +0.00% | 10b5-1 | Stalk |
| Jul 17, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 832 | $20.98 | $2.5B | -40.82% | +26.46% | $17.5K | +0.00% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 10,700 | $27.24 | $2.5B | -40.82% | +26.46% | $291.4K | -1.74% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 34,465 | $19.12 | $2.5B | -40.82% | +26.46% | $659.0K | -1.26% | 10b5-1 | Stalk |
| Jul 9, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 4,342 | $23.15 | $2.5B | -40.82% | +26.46% | $100.5K | +0.00% | 10b5-1 | Stalk |
| Jun 30, 2026 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 75,000 | $26.14 | $2.5B | -40.82% | +26.46% | $2.0M | -5.68% | 10b5-1 | Stalk |
| Jun 26, 2026 | Sell | MLYS | Eric Warren | Chief Commercial Officer | 208,248 | $19.57 | $2.5B | -40.82% | +26.46% | $4.1M | +0.00% | 10b5-1 | Stalk |
| Jun 15, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 22,600 | $20.00 | $2.5B | -40.82% | +26.46% | $452.0K | -1.24% | 10b5-1 | Stalk |
| Jun 10, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,038 | $14.54 | $2.5B | -40.82% | +26.46% | $247.7K | +0.00% | 10b5-1 | Stalk |
| May 18, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 834 | $21.50 | $2.5B | -40.82% | +26.46% | $17.9K | +0.00% | 10b5-1 | Stalk |
| May 11, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 38,801 | $20.35 | $2.5B | -40.82% | +26.46% | $789.7K | -0.85% | 10b5-1 | Stalk |
| Apr 17, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 832 | $23.38 | $2.5B | -40.82% | +26.46% | $19.5K | +0.00% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,730 | $26.83 | $2.5B | -40.82% | +26.46% | $422.0K | -2.23% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 34,464 | $18.89 | $2.5B | -40.82% | +26.46% | $651.0K | -0.99% | 10b5-1 | Stalk |
| Apr 9, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 4,340 | $21.69 | $2.5B | -40.82% | +26.46% | $94.1K | +0.00% | 10b5-1 | Stalk |
| Mar 31, 2026 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 75,000 | $26.27 | $2.5B | -40.82% | +26.46% | $2.0M | -3.34% | 10b5-1 | Stalk |
| Mar 17, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 834 | $20.54 | $2.5B | -40.82% | +26.46% | $17.1K | +0.00% | 10b5-1 | Stalk |
| Mar 12, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 34,463 | $18.73 | $2.5B | -40.82% | +26.46% | $645.3K | -0.76% | 10b5-1 | Stalk |
| Mar 9, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 4,342 | $21.42 | $2.5B | -40.82% | +26.46% | $93.0K | +0.00% | 10b5-1 | Stalk |
| Feb 17, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 834 | $21.52 | $2.5B | -40.82% | +26.46% | $17.9K | +0.00% | 10b5-1 | Stalk |
| Feb 12, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 34,460 | $19.51 | $2.5B | -40.82% | +26.46% | $672.1K | -0.94% | 10b5-1 | Stalk |
| Feb 9, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 4,342 | $23.11 | $2.5B | -40.82% | +26.46% | $100.3K | +0.00% | 10b5-1 | Stalk |
| Jan 20, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 832 | $23.77 | $2.5B | -40.82% | +26.46% | $19.8K | +0.00% | 10b5-1 | Stalk |
| Jan 13, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 26,785 | $26.83 | $2.5B | -40.82% | +26.46% | $718.6K | -2.30% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,758 | $32.14 | $2.5B | -40.82% | +26.46% | $345.7K | -55.47% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 16,236 | $32.62 | $2.5B | -40.82% | +26.46% | $529.6K | -1.25% | 10b5-1 | Stalk |
| Jan 9, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,036 | $18.72 | $2.5B | -40.82% | +26.46% | $318.9K | +0.00% | 10b5-1 | Stalk |
| Jan 2, 2026 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 515,473 | $23.98 | $2.5B | -40.82% | +26.46% | $12.4M | -0.42% | 10b5-1 | Stalk |
| Nov 21, 2025 | Buy | MLYS | Jon Congleton | Chief Executive Officer | 24,082 | $0.54 | $2.5B | -40.82% | +26.46% | $13.0K | +3.81% | — | Stalk |
| Nov 11, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 225,177 | $30.44 | $2.5B | -40.82% | +26.46% | $6.9M | -0.90% | — | Stalk |
| Nov 11, 2025 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 200,000 | $45.44 | $2.5B | -40.82% | +26.46% | $9.1M | -4.25% | — | Stalk |
| Oct 15, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 10,369 | $43.01 | $2.5B | -40.82% | +26.46% | $446.0K | -12.72% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,758 | $42.01 | $2.5B | -40.82% | +26.46% | $452.0K | -4.34% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,100 | $42.67 | $2.5B | -40.82% | +26.46% | $644.3K | -0.90% | 10b5-1 | Stalk |
| Sep 15, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 11,367 | $36.00 | $2.5B | -40.82% | +26.46% | $409.3K | -6.44% | 10b5-1 | Stalk |
| Aug 12, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,714 | $8.68 | $2.5B | -40.82% | +26.46% | $153.8K | -1.76% | 10b5-1 | Stalk |
| Jul 28, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 73,678 | $14.62 | $2.5B | -40.82% | +26.46% | $1.1M | -10.03% | — | Stalk |
| Jul 14, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,715 | $9.75 | $2.5B | -40.82% | +26.46% | $172.7K | -1.67% | 10b5-1 | Stalk |
| Jul 11, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,758 | $14.45 | $2.5B | -40.82% | +26.46% | $155.5K | -4.95% | 10b5-1 | Stalk |
| Jul 11, 2025 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,884 | $14.51 | $2.5B | -40.82% | +26.46% | $230.4K | -1.84% | 10b5-1 | Stalk |
| Jun 12, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,714 | $9.75 | $2.5B | -40.82% | +26.46% | $172.8K | -1.59% | 10b5-1 | Stalk |
| May 14, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $15.29 | $2.5B | -40.82% | +26.46% | $173.8K | -9.63% | 10b5-1 | Stalk |
| May 12, 2025 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 6,349 | $1.08 | $2.5B | -40.82% | +26.46% | $6.9K | +2.98% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 17,714 | $9.71 | $2.5B | -40.82% | +26.46% | $172.0K | -1.07% | 10b5-1 | Stalk |
| Apr 11, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,757 | $12.06 | $2.5B | -40.82% | +26.46% | $129.7K | -4.76% | 10b5-1 | Stalk |
| Apr 11, 2025 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,319 | $12.19 | $2.5B | -40.82% | +26.46% | $186.8K | -1.75% | 10b5-1 | Stalk |
| Apr 1, 2025 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 57,377 | $15.35 | $2.5B | -40.82% | +26.46% | $880.7K | -7.33% | 10b5-1 | Stalk |
| Mar 12, 2025 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 6,349 | $1.08 | $2.5B | -40.82% | +26.46% | $6.9K | +2.26% | — | Stalk |
| Feb 12, 2025 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 6,348 | $1.08 | $2.5B | -40.82% | +26.46% | $6.9K | +2.26% | — | Stalk |
| Jan 13, 2025 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,367 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +2.66% | — | Stalk |
| Jan 13, 2025 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,757 | $9.10 | $2.5B | -40.82% | +26.46% | $97.9K | -2.32% | 10b5-1 | Stalk |
| Jan 13, 2025 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 18,333 | $9.06 | $2.5B | -40.82% | +26.46% | $166.1K | -2.05% | 10b5-1 | Stalk |
| Dec 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 5,017 | $0.54 | $2.5B | -40.82% | +26.46% | $2.7K | +3.44% | — | Stalk |
| Nov 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 15,069 | $5.54 | $2.5B | -40.82% | +26.46% | $83.5K | +0.88% | 10b5-1 | Stalk |
| Nov 6, 2024 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 50,964 | $8.06 | $2.5B | -40.82% | +26.46% | $410.6K | +0.00% | 10b5-1 | Stalk |
| Oct 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 10,369 | $0.82 | $2.5B | -40.82% | +26.46% | $8.5K | +2.37% | — | Stalk |
| Oct 11, 2024 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,757 | $13.57 | $2.5B | -40.82% | +26.46% | $146.0K | -4.34% | 10b5-1 | Stalk |
| Oct 11, 2024 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,271 | $13.52 | $2.5B | -40.82% | +26.46% | $206.4K | -1.68% | 10b5-1 | Stalk |
| Sep 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,367 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +2.68% | — | Stalk |
| Aug 12, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,365 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +2.75% | — | Stalk |
| Jul 16, 2024 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 1,050 | $8.04 | $2.5B | -40.82% | +26.46% | $8.4K | +0.00% | 10b5-1 | Stalk |
| Jul 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +2.83% | — | Stalk |
| Jul 11, 2024 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 10,757 | $13.14 | $2.5B | -40.82% | +26.46% | $141.4K | -4.16% | 10b5-1 | Stalk |
| Jul 11, 2024 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 15,746 | $13.34 | $2.5B | -40.82% | +26.46% | $210.1K | -1.70% | 10b5-1 | Stalk |
| Jun 17, 2024 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 49,313 | $12.01 | $2.5B | -40.82% | +26.46% | $592.0K | -1.71% | 10b5-1 | Stalk |
| Jun 12, 2024 | Sell | MLYS | Jon Congleton | Chief Executive Officer | 72,797 | $12.70 | $2.5B | -40.82% | +26.46% | $924.2K | -2.37% | 10b5-1 | Stalk |
| Jun 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +2.94% | — | Stalk |
| Jun 11, 2024 | Sell | MLYS | Adam Scott Levy | CFO and Secretary | 96,815 | $12.94 | $2.5B | -40.82% | +26.46% | $1.3M | -27.48% | 10b5-1 | Stalk |
| May 13, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +3.02% | — | Stalk |
| May 9, 2024 | Sell | MLYS | David Malcom Rodman | Chief Medical Officer | 200 | $8.04 | $2.5B | -40.82% | +26.46% | $1.6K | +0.00% | 10b5-1 | Stalk |
| Apr 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +3.12% | — | Stalk |
| Mar 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,365 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +3.22% | — | Stalk |
| Feb 12, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,366 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +3.32% | — | Stalk |
| Jan 11, 2024 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 11,365 | $0.84 | $2.5B | -40.82% | +26.46% | $9.6K | +3.44% | — | Stalk |
| Dec 11, 2023 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 5,018 | $0.54 | $2.5B | -40.82% | +26.46% | $2.7K | +6.25% | — | Stalk |
| Nov 22, 2023 | Buy | MLYS | Jon Congleton | Chief Executive Officer | 4,250 | $5.97 | $2.5B | -40.82% | +26.46% | $25.4K | +0.41% | — | Stalk |
| Nov 13, 2023 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 5,017 | $0.54 | $2.5B | -40.82% | +26.46% | $2.7K | +6.25% | — | Stalk |
| Nov 3, 2023 | Buy | MLYS | David Malcom Rodman | Chief Medical Officer | 10,034 | $0.54 | $2.5B | -40.82% | +26.46% | $5.4K | +13.33% | — | Stalk |